Preempt is the international 501(c)(3) ending early-onset cancer through risk-based prevention.
The fastest-growing cancer demographic in the world is the one we are least prepared for: working-age adults. Colorectal cancer in their thirties. Breast cancer in their forties. Every solid tumor is now appearing earlier than the screening guidelines anticipate.
Preempt is built on a single premise: this is preventable. Not curable after the fact — preventable before the fact. Risk-based knowledge, applied early, ends most of these diagnoses before they begin.
Oncology research institutions, global cancer activist organizations, and non-profits are signing the Cancer Alliance Declaration — a shared commitment to risk-based prevention, built to be signed by every employer and every government too.
Advanced-stage (2B) breast cancers, when screening follows personal risk instead of a fixed annual schedule — finding cancer earlier, for the people most likely to have it.
Of new cancer cases are attributable to modifiable risk factors — led by tobacco, infection, and alcohol. Behavior is prevention's largest single lever.
Of all cancers globally are caused by infectious agents — the second-largest category of preventable cancer. HPV and Hepatitis B vaccination closes much of that gap.
Flexible scheduling, mental-health resources, financial navigation — and community, including the Kicking Cancer's Ass podcast — mitigate absenteeism, presenteeism, caregiver burden, and financial toxicity.
What rising early-onset rates mean for you — screening options, what a family history changes, and the questions to bring to your clinician.
Explore individual resourcesThe clinical evidence behind earlier, risk-stratified screening — and how to apply it in practice, from the ISOPT scientific community.
Explore clinical resources at ISOPTWorking-age adults who want to know their cancer risk and act on it — with the screenings, guidance and action plans that knowledge unlocks.
Enter ResourcesResearchers, clinicians and genetic counselors advancing the science of risk-based prevention — through the ISOPT scientific community.
Visit ISOPTCEOs, boards and Chief People Officers building risk-based cancer prevention into the organizations they run — through the Cancer Alliance.
Enter for BusinessWhether you are an individual, a clinician, or the person who decides what your company offers — there is a door here built for you.